13F HOLDINGS REPORT
DAFNA Capital Management LLC
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0001389932-24-000012
Total Value
$439.3M
Positions
72
Other Managers
1
Confidential Omitted
No
Holdings (72)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR S&P BIOTECH ETF | 78464A870 | 431,215 | $40.9M | 9.31% |
| 2 | STEREOTAXIS INC | STXS | 13,680,554 | $35.7M | 8.13% |
| 3 | CYTOKINETICS INC | CYTK | 398,100 | $27.9M | 6.35% |
| 4 | IDEAYA BIOSCIENCES INC | IDYA | 446,341 | $19.6M | 4.46% |
| 5 | MERUS N V | N5749R100 | 378,995 | $17.1M | 3.89% |
| 6 | REVOLUTION MEDICINES INC | RVMDW | 511,894 | $16.5M | 3.76% |
| 7 | VIKING THERAPEUTICS INC | VKTX | 194,117 | $15.9M | 3.62% |
| 8 | SYNDAX PHARMACEUTICALS INC | SNDX | 659,574 | $15.7M | 3.57% |
| 9 | ISHARES NASDAQ BIOTECH INDX | 464287556 | 102,500 | $14.1M | 3.20% |
| 10 | ASCENDIS PHARMA A/S | ASND | 92,472 | $14.0M | 3.18% |
| 11 | XENON PHARMACEUTICALS INC | XENE | 273,739 | $11.8M | 2.68% |
| 12 | DAY ONE BIOPHARMACEUTICALS I | DAWN | 666,463 | $11.0M | 2.51% |
| 13 | BLUEPRINT MEDICINES CORP | 09627Y109 | 106,763 | $10.1M | 2.31% |
| 14 | NEUROCRINE BIOSCIENCES INC | NBIX | 71,615 | $9.9M | 2.25% |
| 15 | KALVISTA PHARMACEUTICALS INC | KALV | 806,973 | $9.6M | 2.18% |
| 16 | TANDEM DIABETES CARE INC | TNDM | 258,208 | $9.1M | 2.08% |
| 17 | DEXCOM INC | DXCM | 65,552 | $9.1M | 2.07% |
| 18 | KURA ONCOLOGY INC | KURA | 412,663 | $8.8M | 2.00% |
| 19 | ATRICURE INC | ATRC | 271,029 | $8.2M | 1.88% |
| 20 | MORPHIC HOLDING INC | 61775R105 | 231,748 | $8.2M | 1.86% |
| 21 | AXOGEN INC | AXGN | 935,894 | $7.6M | 1.72% |
| 22 | BIOHAVEN LTD | BHVN | 118,730 | $6.5M | 1.48% |
| 23 | 2SEVENTY BIO INC | 901384107 | 1,204,051 | $6.4M | 1.47% |
| 24 | EDGEWISE THERAPEUTICS INC | EWTX | 306,197 | $5.6M | 1.27% |
| 25 | ALECTOR INC | ALEC | 912,928 | $5.5M | 1.25% |
| 26 | CENTURY THERAPEUTICS INC | IPSC | 1,307,407 | $5.5M | 1.24% |
| 27 | LARIMAR THERAPEUTICS INC | LRMR | 656,373 | $5.0M | 1.13% |
| 28 | ASCENDIS PHARMA A/S | ASND | 4,000,000 | $4.6M | 1.05% |
| 29 | KEROS THERAPEUTICS INC | KROS | 67,754 | $4.5M | 1.02% |
| 30 | ARCUS BIOSCIENCES INC | RCUS | 231,717 | $4.4M | 1.00% |
| 31 | GALAPAGOS NV | GLPGF | 130,175 | $4.2M | 0.95% |
| 32 | PERSPECTIVE THERAPEUTICS INC | CATX | 3,103,644 | $3.7M | 0.84% |
| 33 | BIOCRYST PHARMACEUTICALS INC | BCRX | 709,500 | $3.6M | 0.82% |
| 34 | ASTRIA THERAPEUTICS INC | 04635X102 | 223,265 | $3.1M | 0.72% |
| 35 | REGULUS THERAPEUTICS INC | 75915K309 | 1,070,548 | $3.1M | 0.70% |
| 36 | BICYCLE THERAPEUTICS PLC | BCYC | 122,200 | $3.0M | 0.69% |
| 37 | ACCURAY INC | ARAY | 1,222,358 | $3.0M | 0.69% |
| 38 | INSULET CORP | PODD | 15,900 | $2.7M | 0.62% |
| 39 | PROCEPT BIOROBOTICS CORP | PRCT | 54,995 | $2.7M | 0.62% |
| 40 | MEDIWOUND LTD | MDWD | 188,753 | $2.7M | 0.61% |
| 41 | ARS PHARMACEUTICALS INC | SPRY | 239,194 | $2.4M | 0.56% |
| 42 | AQUESTIVE THERAPEUTICS INC | AQST | 500,000 | $2.1M | 0.48% |
| 43 | PROQR THERAPEUTICS N V | N71542109 | 905,582 | $2.1M | 0.47% |
| 44 | COMPASS PATHWAYS PLC | CMPS | 243,210 | $2.0M | 0.46% |
| 45 | LINEAGE CELL THERAPEUTICS IN | 53566P109 | 1,366,308 | $2.0M | 0.46% |
| 46 | STOKE THERAPEUTICS INC | STOK | 145,000 | $2.0M | 0.45% |
| 47 | SUTRO BIOPHARMA INC | STRO | 334,079 | $1.9M | 0.43% |
| 48 | INOGEN INC | INGN | 208,790 | $1.7M | 0.38% |
| 49 | GOSSAMER BIO INC | GOSS | 1,409,262 | $1.7M | 0.38% |
| 50 | BRAINSWAY LTD | BRSYF | 297,655 | $1.6M | 0.36% |
| 51 | BIONTECH SE | BNTX | 17,000 | $1.6M | 0.36% |
| 52 | IMMATICS NV | IMTX | 145,000 | $1.5M | 0.35% |
| 53 | NEURONETICS INC | STIM | 313,717 | $1.5M | 0.34% |
| 54 | ADICET BIO INC | ACET | 600,000 | $1.4M | 0.32% |
| 55 | AUTOLUS THERAPEUTICS PLC | AUTL | 216,667 | $1.4M | 0.31% |
| 56 | ACELYRIN INC | 00445A100 | 202,587 | $1.4M | 0.31% |
| 57 | ITEOS THERAPEUTICS INC | 46565G104 | 98,560 | $1.3M | 0.31% |
| 58 | MINERALYS THERAPEUTICS INC | MLYS | 90,000 | $1.2M | 0.26% |
| 59 | COMPUGEN LTD | CGEN | 430,202 | $1.1M | 0.25% |
| 60 | IMMUNOVANT INC | IMVT | 29,416 | $950,431 | 0.22% |
| 61 | ACRIVON THERAPEUTICS INC | ACRV | 131,351 | $939,160 | 0.21% |
| 62 | APREA THERAPEUTICS INC | APRE | 137,174 | $917,694 | 0.21% |
| 63 | POLYPID LTD | PYPD | 185,446 | $853,052 | 0.19% |
| 64 | SYROS PHARMACEUTICALS INC | 87184Q206 | 135,850 | $726,798 | 0.17% |
| 65 | ADAPTIMMUNE THERAPEUTICS PLC | ADTI | 341,064 | $538,881 | 0.12% |
| 66 | MASIMO CORP | MASI | 3,000 | $440,550 | 0.10% |
| 67 | NEVRO CORP | 64157F103 | 28,000 | $404,320 | 0.09% |
| 68 | KARYOPHARM THERAPEUTICS INC | KPTI | 192,678 | $290,944 | 0.07% |
| 69 | VIGIL NEUROSCIENCE INC | 92673K108 | 71,815 | $244,889 | 0.06% |
| 70 | COMPASS THERAPEUTICS INC | CMPX | 116,882 | $231,426 | 0.05% |
| 71 | SPERO THERAPEUTICS INC | SPRO | 125,000 | $215,000 | 0.05% |
| 72 | ALTO NEUROSCIENCE INC | ANRO | 10,000 | $153,500 | 0.03% |